Abstract:
Prostate cancer is the second leading cause of cancer death in North America, and becomes significant in Europe and Asia. Hormonal therapy, the current remedy for metastatic prostate cancer is not curative and causes various adverse effects. We discover administration of HDHS by targeting the intracellular activity of androgen receptor and inducing cell apoptosis as a highly effective way to control prostate cancer growth. Thus, the HDHS compound and its derivatives are valuable in treating androgen-regulated diseases, including prostate cancer, benign prostate hypertrophy, male alopecia, acne, and breast cancer etc.
Fields of Application:
1.As therapeutics for prostate cancer and benign prostate hypertrophy. 2.Additional androgen-regulated diseases, e.g. alopecia, acnes, osteoporosis, oily skin, breast cancer, etc.
Advantages when compared to the existing technologies:
Natural products and proved effective on both AR-positive prostate cancer and potentially effective on AR-negative prostate cancer.
Contact Person:Mei-Ching Chen Tel: 886-2-27899383 ext 111 cmj@gate.sinica.edu.tw
IP Status:US 8519007 TW I 434680
